Steroid-Responsive Nephrotic Syndrome of Childhood: A Long-Term Study of Clinical Course, Histopathology, Efficacy of Cyclophosphamide Therapy, and Effects on Growth

https://doi.org/10.1016/S0272-6386(87)80087-2Get rights and content
Under a Creative Commons license
open archive

The long-term clinical course of 60 children with steroid-responsive nephrotic syndrome, observed for a minimum of 10 years from onset, was studied (mean 14.5 ± 0.5 years). Four children had only a single episode, seven children experienced only one to three relapses early in their course, and the remaining 49 patients (82%) experienced frequently relapsing steroid-dependent disease. Nearly half of these (47%) continued to relapse into their late teens and early twenties. All 20 children treated with cyclosphosphamide because of steroid-induced side effects developed complete remissions of the nephrotic syndrome. These were sustained in 70% for 9.1 ± 0.6 years, with a reduction of disease severity in the remaining 30%. In contrast, only 48% of patients treated with prednisone alone were in remission at last follow-up (P = .06). Ten of the children treated with cyclophosphamide had the minimal change lesion prior to therapy; 90% of these had permanent remissions. Only 50% of the six children with focal glomerulosclerosis and four children with mesangial proliferation have had permanent remissions. None of the patients developed renal insufficiency. Children treated with prednisone alone were −0.93 ± 0.3 SD below the mean for height at last follow-up. Cyclophosphamide treatment was associated with an increase in height SD scores from −0.84 ± 0.4 to −0.28 ± 0.3. Children with severe growth impairment demonstrated dramatic catch-up growth when treated with cyclophosphamide with SD scores increasing from −2.29 ± 0.8 to −0.43 ± 0.6 (P < .05). It is concluded that steroid-responsive nephrotic syndrome often follows a frequently relapsing steroid-dependent course for as long as 25 years. Cyclophosphamide favorably alters the course of this disease, particularly in patients with a minimal change lesion, and ameliorates steroid-induced growth retardation. In our experience, frequently relapsing steroid-dependent nephrotic syndrome, even when associated with lateonset focal glomerulosclerosis, did not result in renal insufficiency.

Index Words

Nephrotic syndrome
cyclophosphamide
growth retardation

Cited by (0)

Portions of this work were presented at the meeting of the Society for Pediatric Research, May 6, 1985, Washington, DC